| Financial Year |
March 31 2023 |
| Monetary Funds |
334,692,404.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,376,000.00 |
| Accounts Receivable |
1,129,895,324.62 |
| Advances to Suppliers |
95,895,938.30 |
| Other Receivables |
269,024,730.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
565,067,339.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
82,121,539.75 |
| Total Current Assets |
2,532,066,826.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,976,946.24 |
| Investment Properties |
-- |
| Fixed Assetes |
3,372,879,358.15 |
| Under-construction Projects |
557,751,432.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
217,743,055.26 |
| R&D expenses |
-- |
| Goodwill |
44,857,185.73 |
| Long-Term Deferred and Prepaid Expenses |
2,692,949.31 |
| Deferred Income Tax Assets |
235,247,190.16 |
| Other Non-Current Assets |
516,786,375.84 |
| Sub-Total of Non-Current Assets |
4,965,039,903.12 |
| Total Assets |
7,497,106,729.54 |
| Short-Term Loans |
1,480,413,674.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,551,819.72 |
| Accounts Payable |
290,574,784.82 |
| Accounts Received In Advance |
129,696.00 |
| Employee Compensation Payable |
4,983,950.31 |
| Taxes Payable |
20,987,416.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,322,546.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,765,932.08 |
| Other Current Liabilities |
25,581,911.07 |
| Sub-Total of Current Liabilities |
2,089,447,025.11 |
| Long-term Loans |
110,497,407.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
100,372,197.85 |
| Deferred Income Tax Liabilities |
44,662,251.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
281,176,949.31 |
| Total Liabilities |
2,370,623,974.42 |
| Paid-In Capital(Or Share Stock) |
2,503,942,925.00 |
| Capital Surplus |
3,884,134,901.05 |
| Surplus Reserve |
125,633,905.67 |
| LESS:Treasury Stock |
102,622,345.78 |
| Undistributed Profits |
-1,269,505,709.83 |
| Minority Stockholder's Interest |
17,857,457.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,108,625,297.26 |
| Owner's Equity（Stockholder's Equity） |
5,126,482,755.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,497,106,729.54 |
